Nouvelles et médias

Pour les publications sélectionnées relatives à la plateforme EnhanceTM­d’ExCellThera et à la petite molécule brevetée UM171, voir

Cohen S, et al., Improved Outcomes of UM171-Expanded Cord Blood Transplantation Compared with Other Graft Sources: Real-World Evidence, Blood Advances (2023)

Tellechea MF, et al., Towards clinically meaningful expansion of human HSCs, Cell Research (2023)

Dumont-Lagacé M, et al., UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities, Transplantation and Cellular Therapy (2022)

Dumont-Lagacé M. et al., ECTmatch: Optimizing Small-Scale Cord Blood Banking Through HLA Analysis, Stem Cells Translational Medicine (2022)

Dumont-Lagacé M, et al., UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections, Transplantation and Cellular Therapy (2021)

Cohen S, et al., Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1–2 safety and feasibility study, The Lancet Haematology (2020)

Claveau J-S, et al., Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors, European Journal of Haematology (2020)